Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Natera Inc
(NQ:
NTRA
)
130.39
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Natera Inc
< Previous
1
2
3
4
5
6
Next >
Pinterest, Checkpoint Therapeutics And 2 Other Stocks Insiders Are Selling
February 05, 2024
The Nasdaq 100 closed higher by around 300 points on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Expert Ratings For Natera
January 17, 2024
Via
Benzinga
Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle
January 17, 2024
The company must pay $57 million in damages, but that's far less than expected.
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
January 17, 2024
Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market...
Via
Benzinga
Progress Software Posts Strong Q4 Results, Joins Impinj, REGENXBIO And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
January 17, 2024
U.S. stock futures were lower this morning, with the Dow Jones futures falling more than 100 points on Wednesday. Shares of Progress Software Corporation (NASDAQ: PRGS) rose in pre-market trading as...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Analyst Landscape: 8 Takes On Natera
December 29, 2023
Via
Benzinga
The Latest Analyst Ratings for Natera
December 12, 2023
Via
Benzinga
Bull of the Day - NeoGenomics
January 12, 2024
But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context.
Via
Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 29, 2023
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Via
Benzinga
Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
December 29, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit
December 28, 2023
Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina district court, which prohibits the company from
Via
Benzinga
Top 5 Health Care Stocks That May Collapse In November
November 17, 2023
As of Nov. 17, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
Analyst Expectations for Natera's Future
November 09, 2023
Via
Benzinga
Analyst Ratings for Natera
October 16, 2023
Via
Benzinga
The Latest Analyst Ratings for Natera
August 08, 2023
Via
Benzinga
Disney, Twilio, TransDigm, Marathon Digital And Other Big Stocks Moving Higher On Thursday
November 09, 2023
U.S. stocks traded mostly lower, with the Dow Jones falling around 75 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bull Of The Day: NeoGenomics
October 24, 2023
NeoGenomics is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer.
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
August 04, 2023
Via
Benzinga
Why Natera Stock Is Soaring Today
August 04, 2023
This DNA testing leader passed the test in Q2.
Via
The Motley Fool
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Natera Earnings Preview
August 02, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Natera
July 21, 2023
Via
Benzinga
Analyst Expectations for Natera's Future
May 30, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via
Benzinga
Investors Cheer Jobs Report: Why Are These 5 Stocks And 5 ETFs Shining On Friday?
August 04, 2023
Via
Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
August 04, 2023
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
Via
Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
August 04, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 03, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
May 26, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.